CL2004001244A1 - Procedimientos para preparar 2-(1-azabiciclo[2.2.2]oct-3-il)-3-hidroxi-2,3,3a,4,5,6-hexahidro-1h-benz[de]isoquinolin-1-ona por hidrogenacion, deshidratacion e hidrogenacion de la correspondiente 1,3 diona, utiles como antagonistas del receptor 5-ht3; - Google Patents

Procedimientos para preparar 2-(1-azabiciclo[2.2.2]oct-3-il)-3-hidroxi-2,3,3a,4,5,6-hexahidro-1h-benz[de]isoquinolin-1-ona por hidrogenacion, deshidratacion e hidrogenacion de la correspondiente 1,3 diona, utiles como antagonistas del receptor 5-ht3;

Info

Publication number
CL2004001244A1
CL2004001244A1 CL200401244A CL2004001244A CL2004001244A1 CL 2004001244 A1 CL2004001244 A1 CL 2004001244A1 CL 200401244 A CL200401244 A CL 200401244A CL 2004001244 A CL2004001244 A CL 2004001244A CL 2004001244 A1 CL2004001244 A1 CL 2004001244A1
Authority
CL
Chile
Prior art keywords
hydrogenation
isoquinolin
benz
oct
azabiciclo
Prior art date
Application number
CL200401244A
Other languages
English (en)
Inventor
A Kowalczyk Charles A Dv Bruce
Original Assignee
Roche Palo Alto Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004001244(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Palo Alto Llc filed Critical Roche Palo Alto Llc
Publication of CL2004001244A1 publication Critical patent/CL2004001244A1/es
Priority to CL200701958A priority Critical patent/CL2007001958A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200401244A 1994-07-08 2004-05-20 Procedimientos para preparar 2-(1-azabiciclo[2.2.2]oct-3-il)-3-hidroxi-2,3,3a,4,5,6-hexahidro-1h-benz[de]isoquinolin-1-ona por hidrogenacion, deshidratacion e hidrogenacion de la correspondiente 1,3 diona, utiles como antagonistas del receptor 5-ht3; CL2004001244A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL200701958A CL2007001958A1 (es) 1994-07-08 2007-07-05 Procedimiento para preparar 2-(1-azabiciclo-[2.2.2]oct-3-il)-2,4,5,6-tetrahidro-1h-benz[de]isoquinolin-1-ona, sus sales y estereoisomeros individuales (divisional sol.1244-04).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein

Publications (1)

Publication Number Publication Date
CL2004001244A1 true CL2004001244A1 (es) 2005-04-15

Family

ID=23040964

Family Applications (2)

Application Number Title Priority Date Filing Date
CL200401244A CL2004001244A1 (es) 1994-07-08 2004-05-20 Procedimientos para preparar 2-(1-azabiciclo[2.2.2]oct-3-il)-3-hidroxi-2,3,3a,4,5,6-hexahidro-1h-benz[de]isoquinolin-1-ona por hidrogenacion, deshidratacion e hidrogenacion de la correspondiente 1,3 diona, utiles como antagonistas del receptor 5-ht3;
CL200701958A CL2007001958A1 (es) 1994-07-08 2007-07-05 Procedimiento para preparar 2-(1-azabiciclo-[2.2.2]oct-3-il)-2,4,5,6-tetrahidro-1h-benz[de]isoquinolin-1-ona, sus sales y estereoisomeros individuales (divisional sol.1244-04).

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL200701958A CL2007001958A1 (es) 1994-07-08 2007-07-05 Procedimiento para preparar 2-(1-azabiciclo-[2.2.2]oct-3-il)-2,4,5,6-tetrahidro-1h-benz[de]isoquinolin-1-ona, sus sales y estereoisomeros individuales (divisional sol.1244-04).

Country Status (16)

Country Link
US (1) US5567818A (es)
EP (1) EP0770077B1 (es)
JP (1) JP2898758B2 (es)
CN (1) CN1048727C (es)
AT (1) ATE205845T1 (es)
AU (1) AU2979995A (es)
BR (1) BR9508249A (es)
CL (2) CL2004001244A1 (es)
CY (1) CY2342B1 (es)
DE (1) DE69522808T2 (es)
DK (1) DK0770077T3 (es)
ES (1) ES2162929T3 (es)
FI (1) FI120198B (es)
MX (1) MX9700157A (es)
PT (1) PT770077E (es)
WO (1) WO1996001824A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522018A (en) 2000-04-20 2003-09-26 Masonite Corp Reverse molded fibreboard panel
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
US7737280B2 (en) * 2006-10-23 2010-06-15 Sicor Inc. Processes for preparing palonosetron salts
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
WO2008146283A2 (en) * 2007-05-29 2008-12-04 Chemagis Ltd. Novel palonosetron salts and processes for preparation and purification thereof
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
EP2364312A4 (en) * 2008-11-11 2012-05-02 Reddys Lab Ltd Dr SYNTHESIS OF CRYSTALLINE PALONOSETRON CHLORHYDRATE
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc １，８−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
PL166277B1 (pl) * 1989-11-28 1995-04-28 Syntex Inc Sposób wytwarzania nowych zwiazków trójpierscieniowych PL PL PL PL
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
ES2162929T3 (es) 2002-01-16
EP0770077B1 (en) 2001-09-19
FI120198B (fi) 2009-07-31
DE69522808D1 (de) 2001-10-25
JP2898758B2 (ja) 1999-06-02
CN1048727C (zh) 2000-01-26
CN1152313A (zh) 1997-06-18
FI970068A (fi) 1997-01-07
EP0770077A1 (en) 1997-05-02
WO1996001824A1 (en) 1996-01-25
PT770077E (pt) 2002-02-28
DE69522808T2 (de) 2002-04-04
DK0770077T3 (da) 2002-01-14
CL2007001958A1 (es) 2008-02-22
BR9508249A (pt) 1998-01-06
MX9700157A (es) 1997-04-30
CY2342B1 (en) 2004-02-06
US5567818A (en) 1996-10-22
AU2979995A (en) 1996-02-09
ATE205845T1 (de) 2001-10-15
FI970068A0 (fi) 1997-01-07
JPH09508645A (ja) 1997-09-02

Similar Documents

Publication Publication Date Title
CL2004001244A1 (es) Procedimientos para preparar 2-(1-azabiciclo[2.2.2]oct-3-il)-3-hidroxi-2,3,3a,4,5,6-hexahidro-1h-benz[de]isoquinolin-1-ona por hidrogenacion, deshidratacion e hidrogenacion de la correspondiente 1,3 diona, utiles como antagonistas del receptor 5-ht3;
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
ES2076303T3 (es) Derivados de decahidro isoquinoleina, procedimiento para su preparacion y su uso como medicinas.
ES2155844T3 (es) Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos.
EA199800340A1 (ru) Производные пиримидина как антагонисты 5нт2с
WO2001034603A3 (en) Bicyclic and tricyclic heteroaromatic compounds
ES2195163T3 (es) Derivados de pirimidina biciclicos y su uso como anticoagulantes.
ATE354364T1 (de) Verwendung von at-1 rezeptorantagonisten oder at- 2 rezeptormodulatoren zur behandlung von erkrankungen, die mit einer erhöhung an at-1 oder at-2 rezeptoren verbunden sind
ZA952382B (en) Naphthalamides as central nervous system agents
ATE226247T1 (de) Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
AU5608000A (en) 22025, a novel human cyclic nucleotide phosphodiesterase
PT1129091E (pt) Antagonistas de receptor de crf e metodos relacionados
NO994850L (no) Farmakologiske midler
ES2105664T3 (es) Procedimiento para la preparacion y resolucion de 2-fenil-3-aminopiperidina.
EA199700242A1 (ru) Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора
ES2152682T3 (es) Derivados de indolina utiles como antagonistas del receptor 5ht-2c.
PT90716A (pt) Processo aperfeicoado para a preparacao de derivados de ariloxipropanolamina uteis como antagonistas de serotonina
PT96084A (pt) Processo para a preparacao de ciclo-hexenos substituidos utilizados como agentes do sistema nervoso central
ATE258176T1 (de) Neue azabicyclo derivate und ihre verwendung
FR2738569B1 (fr) Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
ES2187783T3 (es) Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.
MY117754A (en) Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives
PT85570B (fr) Procede de preparation de derives de 2,3-dihydro furanne utilisables comme intermediaires pour la preparation de tetrahydrofuranne
ES2128698T3 (es) Procedimiento para la obtencion de 8-alfa,12-oxido-13,14,15,16-tetranorlabdano.
YU32691A (sh) 6-supstituisani-heksahidrobenz c,d indoli i postupak za njegovo dobijanje